Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression
Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3667-3668
DOI: 10.1111/jgh.70788 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 01.10.2026. Verfasst von Yao Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Medical University, Shijiazhuang, China. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Autor:innen und Institutionen
- Hebei Medical University, Shijiazhuang, China.
- Department of Medicine Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Yao Liu, Yibing Liu
Zitieren
APA
Liu, Y., & Liu, Y. (2026). Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression. Journal of Gastroenterology and Hepatology, 41(11), 3667-3668. https://doi.org/10.1111/jgh.70788
Vancouver
Liu Y, Liu Y. Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression. Journal of Gastroenterology and Hepatology. 2026;41(11):3667-3668. doi:10.1111/jgh.70788
BibTeX
@article{Liu2026,
author = {Liu, Yao and Liu, Yibing},
title = {Defining Helicobacter pylori –Related Enhancement of Tegoprazan Acid Suppression},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {11},
pages = {3667--3668},
doi = {10.1111/jgh.70788}
}
EUVIMED